Stock TTALO TERVEYSTALO OYJ
Add to a list
To use this feature you must be a member
Log inSign up

Financials Terveystalo Oyj

Equities

TTALO

FI4000252127

Healthcare Facilities & Services

Market Closed - Nasdaq Helsinki
Other stock markets
 11:29:51 2024-04-30 am EDT 		5-day change 1st Jan Change
8.71 EUR +1.28% Intraday chart for Terveystalo Oyj +7.13% +12.53%
Apr. 26 Transcript : Terveystalo Oyj, Q1 2024 Earnings Call, Apr 26, 2024
Apr. 26 Terveystalo Oyj Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 1,423 1,278 1,495 790.9 979.5 1,102 - -
Enterprise Value (EV) 1 1,971 1,769 2,014 1,358 1,578 1,641 1,566 1,550
P/E ratio 26 x 27.9 x 18.8 x 32.9 x -23.5 x 15.9 x 12.4 x 11.1 x
Yield 2.33% 1.29% 2.36% 4.48% 3.88% 3.79% 3.96% 4.48%
Capitalization / Revenue 1.38 x 1.3 x 1.3 x 0.63 x 0.76 x 0.83 x 0.8 x 0.77 x
EV / Revenue 1.91 x 1.79 x 1.74 x 1.08 x 1.23 x 1.23 x 1.13 x 1.08 x
EV / EBITDA 11.2 x 10.9 x 9.77 x 7.63 x 7.88 x 7.4 x 6.61 x 6.27 x
EV / FCF 14.1 x 16 x 13.2 x 16.6 x 13.5 x 13.3 x 11.3 x 10.8 x
FCF Yield 7.1% 6.25% 7.55% 6.02% 7.42% 7.52% 8.82% 9.27%
Price to Book 2.64 x 2.25 x 2.49 x 1.33 x 1.9 x 2 x 1.85 x 1.7 x
Nbr of stocks (in thousands) 127,307 127,307 126,307 126,548 126,556 126,556 - -
Reference price 2 11.18 10.04 11.84 6.250 7.740 8.710 8.710 8.710
Announcement Date 2/13/20 2/11/21 2/10/22 2/10/23 2/14/24 - - -
1EUR in Million2EUR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 1,031 986.4 1,155 1,259 1,286 1,332 1,384 1,430
EBITDA 1 176.3 162.8 206.1 178 200.2 221.7 236.8 247.1
EBIT 1 86.5 71.6 114.4 33.9 -14.7 114.4 135.9 146.6
Operating Margin 8.39% 7.26% 9.91% 2.69% -1.14% 8.59% 9.82% 10.25%
Earnings before Tax (EBT) 1 66.8 56.6 100.7 30.9 -38.9 87.61 112.1 125.9
Net income 1 54.1 45.8 80.5 24.4 -42.2 69.69 89.06 99.9
Net margin 5.25% 4.64% 6.97% 1.94% -3.28% 5.23% 6.44% 6.98%
EPS 2 0.4300 0.3600 0.6300 0.1900 -0.3300 0.5484 0.7008 0.7870
Free Cash Flow 1 140 110.6 152.1 81.7 117 123.5 138.2 143.7
FCF margin 13.58% 11.21% 13.17% 6.49% 9.1% 9.27% 9.99% 10.04%
FCF Conversion (EBITDA) 79.41% 67.94% 73.8% 45.9% 58.44% 55.68% 58.35% 58.14%
FCF Conversion (Net income) 258.78% 241.48% 188.94% 334.84% - 177.17% 155.18% 143.81%
Dividend per Share 2 0.2600 0.1300 0.2800 0.2800 0.3000 0.3300 0.3450 0.3900
Announcement Date 2/13/20 2/11/21 2/10/22 2/10/23 2/14/24 - - -
1EUR in Million2EUR
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales 1 327.5 329.7 318.2 276.4 334.8 341.1 322.4 280.5 342.4 350.2 333.2 292.2 357.4
EBITDA 1 59.1 56.6 42.4 30.9 48 55.3 47.1 39.7 58.1 65.7 50.25 44.25 62.45
EBIT 1 34.8 31.2 14.6 -24.6 12.8 19.1 15 10.2 -58.9 35.7 23.7 17.95 36.05
Operating Margin 10.63% 9.46% 4.59% -8.9% 3.82% 5.6% 4.65% 3.64% -17.2% 10.19% 7.11% 6.14% 10.09%
Earnings before Tax (EBT) 1 31.8 31.3 14.1 -24.3 9.8 14.1 9.8 3.6 -66.4 29.6 10.77 14.13 28.89
Net income 1 25.8 24.9 11.1 -19.6 7.6 11.1 7.5 3.3 -64.1 23.6 5.05 11.9 23.42
Net margin 7.88% 7.55% 3.49% -7.09% 2.27% 3.25% 2.33% 1.18% -18.72% 6.74% 1.52% 4.07% 6.55%
EPS 2 0.2000 0.2000 0.0900 -0.1500 0.0600 0.0900 0.0600 0.0300 -0.5100 0.1900 0.0666 0.0886 0.1823
Dividend per Share - - - - - - - - 0.3000 - - - -
Announcement Date 2/10/22 4/28/22 7/19/22 10/27/22 2/10/23 4/28/23 7/18/23 10/27/23 2/14/24 4/26/24 - - -
1EUR in Million2EUR
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 548 491 519 567 598 539 464 448
Net Cash position 1 - - - - - - - -
Leverage (Debt/EBITDA) 3.109 x 3.015 x 2.518 x 3.183 x 2.988 x 2.43 x 1.958 x 1.813 x
Free Cash Flow 1 140 111 152 81.7 117 123 138 144
ROE (net income / shareholders' equity) 10.3% 8.23% 13.6% 4.1% 11.8% 13.4% 15.6% 16.4%
ROA (Net income/ Total Assets) 4.3% 3.37% 5.73% 1.67% -2.91% 5% 6.32% 6.86%
Assets 1 1,258 1,360 1,405 1,464 1,449 1,395 1,409 1,457
Book Value Per Share 2 4.230 4.460 4.760 4.700 4.070 4.340 4.720 5.110
Cash Flow per Share 2 1.360 1.130 1.530 1.110 1.250 1.520 1.590 1.600
Capex 1 33.6 33.1 43.1 59.2 41 42.5 52.2 64.8
Capex / Sales 3.26% 3.36% 3.73% 4.7% 3.19% 3.19% 3.77% 4.53%
Announcement Date 2/13/20 2/11/21 2/10/22 2/10/23 2/14/24 - - -
1EUR in Million2EUR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Terveystalo Oyj

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
8.71 EUR
Average target price
9.7 EUR
Spread / Average Target
+11.37%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Hospitals, Clinics & Primary Care Services

1st Jan change Capi.
TERVEYSTALO OYJ Stock Terveystalo Oyj
+12.53% 1.18B
AIER EYE HOSPITAL GROUP CO., LTD. Stock Aier Eye Hospital Group Co., Ltd.
-18.46% 16.57B
BANGKOK DUSIT MEDICAL SERVICES Stock Bangkok Dusit Medical Services
+4.50% 12.4B
IHH HEALTHCARE Stock IHH Healthcare
+4.98% 11.69B
APOLLO HOSPITALS ENTERPRISE LIMITED Stock Apollo Hospitals Enterprise Limited
+4.26% 10.24B
RAMSAY HEALTH CARE LIMITED Stock Ramsay Health Care Limited
-2.32% 7.76B
MOUWASAT MEDICAL SERVICES COMPANY Stock Mouwasat Medical Services Company
+20.21% 7.17B
THE ENSIGN GROUP, INC. Stock The Ensign Group, Inc.
+6.45% 6.74B
GLOBAL HEALTH LIMITED Stock Global Health Limited
+50.68% 4.65B
DALLAH HEALTHCARE COMPANY Stock Dallah Healthcare Company
-5.12% 4.25B
Hospitals, Clinics & Primary Care Services
  1. Stock Market
  2. Equities
  3. TTALO Stock
  4. Financials Terveystalo Oyj